+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Bioresorbable Medical Material Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 260 Pages
  • September 2024
  • Region: Global
  • Allied Market Research
  • ID: 6054012
Description Jump to:
The bioresorbable medical material market was valued at $0.4 billion in 2023, and is projected to reach $1.2 billion by 2033, growing at a CAGR of 10.6% from 2024 to 2033.

Bioresorbable medical material refers to a class of materials designed to dissolve or be absorbed by the body over time after serving their medical purpose. These materials are used in various medical applications, such as implants, sutures, and drug delivery systems, where temporary support or function is required.

Rise in demand for minimally invasive surgical procedures has fueled the adoption of bioresorbable materials, which reduce the need for follow-up surgeries to remove implants or sutures. In addition, increase in prevalence of cardiovascular diseases, orthopedic disorders, and other chronic conditions among aging populations is creating a higher demand for bioresorbable implants and devices, thereby driving the growth of the global bioresorbable medical material market. Moreover, healthcare providers are increasingly focused on improving patient outcomes and reducing the risk of complications, making bioresorbable materials appealing due to their ability to dissolve naturally without requiring additional surgical interventions.

Furthermore, the growing field of tissue engineering and regenerative medicine is significantly contributing to the demand for bioresorbable scaffolds and materials that promote tissue repair and regeneration. Increase in awareness among healthcare professionals and patients regarding the benefits of biocompatible, bioresorbable materials over conventional, non-absorbable alternatives is further driving the market growth. However, high costs associated with development and manufacturing bioresorbable materials restrain the market growth.

In addition, availability of established conventional non-resorbable materials like titanium and stainless steel acts as a key deterrent factor of the market. On the contrary, advances in medical device technologies, such as bioresorbable stents and screws, have boosted the adoption of these materials in orthopedic, dental, and cardiovascular applications. Such developments are expected to open new avenues for the expansion of the global market during the forecast period.

The bioresorbable medical material industry is segmented into product type, application, and region. On the basis of product type, the market is bifurcated into polylactide (PLA), poly-L-lactide (PLLA), poly-DL-lactide (PDLLA), polyglycolide (PGA), polycaprolactone (PCL), and others. Depending on application, it is divided into drug delivery, medical devices, orthopedics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the polylactide (PLA) segment is expected to dominate the market from 2024 to 2033.

Depending on application, orthopedics is anticipated to be the largest segment in the bioresorbable medical materials market.

Region wise, North America held the largest market share in terms of revenue in 2023, and is expected to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bioresorbable medical material market include Medtronic, Stryker Corporation, Johnson & Johnson, Boston Scientific Corporation, Smith & Nephew Plc, Zimmer Biomet Holdings, Inc., B . Braun Melsungen AG, KLS Martin Group, Dare Bioscience, Inc., and Amedica Corporation. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update* (with the purchase of an enterprise license)
  • 5 additional Company Profiles, pre- or post-purchase, as a free update.
  • Free Updated Version (once released) with the purchase of an enterprise user license.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Product Type

  • Polylactide
  • Poly-L-lactide
  • Poly-DL-lactide
  • Polyglycolide
  • Polycaprolactone
  • Others

By Application

  • Drug Delivery
  • Medical Devices
  • Orthopedics
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • Medtronic
  • Stryker Corporation.
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Smith & Nephew plc
  • Zimmer Biomet Holdings, Inc.
  • B . Braun Melsungen AG
  • KLS Martin Group
  • Dare Bioscience, Inc.
  • amedica corporation

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: BIORESORBABLE MEDICAL MATERIAL MARKET, BY PRODUCT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product Type
4.2. Polylactide
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Poly-L-lactide
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Poly-DL-lactide
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Polyglycolide
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Polycaprolactone
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.7. Others
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
CHAPTER 5: BIORESORBABLE MEDICAL MATERIAL MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Drug Delivery
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Medical Devices
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Orthopedics
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Others
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: BIORESORBABLE MEDICAL MATERIAL MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product Type
6.2.3. Market Size and Forecast, By Application
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Bioresorbable Medical Material Market
6.2.5.1. Market Size and Forecast, By Product Type
6.2.5.2. Market Size and Forecast, By Application
6.2.6. Canada Bioresorbable Medical Material Market
6.2.6.1. Market Size and Forecast, By Product Type
6.2.6.2. Market Size and Forecast, By Application
6.2.7. Mexico Bioresorbable Medical Material Market
6.2.7.1. Market Size and Forecast, By Product Type
6.2.7.2. Market Size and Forecast, By Application
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product Type
6.3.3. Market Size and Forecast, By Application
6.3.4. Market Size and Forecast, By Country
6.3.5. France Bioresorbable Medical Material Market
6.3.5.1. Market Size and Forecast, By Product Type
6.3.5.2. Market Size and Forecast, By Application
6.3.6. Germany Bioresorbable Medical Material Market
6.3.6.1. Market Size and Forecast, By Product Type
6.3.6.2. Market Size and Forecast, By Application
6.3.7. Italy Bioresorbable Medical Material Market
6.3.7.1. Market Size and Forecast, By Product Type
6.3.7.2. Market Size and Forecast, By Application
6.3.8. Spain Bioresorbable Medical Material Market
6.3.8.1. Market Size and Forecast, By Product Type
6.3.8.2. Market Size and Forecast, By Application
6.3.9. UK Bioresorbable Medical Material Market
6.3.9.1. Market Size and Forecast, By Product Type
6.3.9.2. Market Size and Forecast, By Application
6.3.10. Rest Of Europe Bioresorbable Medical Material Market
6.3.10.1. Market Size and Forecast, By Product Type
6.3.10.2. Market Size and Forecast, By Application
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product Type
6.4.3. Market Size and Forecast, By Application
6.4.4. Market Size and Forecast, By Country
6.4.5. China Bioresorbable Medical Material Market
6.4.5.1. Market Size and Forecast, By Product Type
6.4.5.2. Market Size and Forecast, By Application
6.4.6. Japan Bioresorbable Medical Material Market
6.4.6.1. Market Size and Forecast, By Product Type
6.4.6.2. Market Size and Forecast, By Application
6.4.7. India Bioresorbable Medical Material Market
6.4.7.1. Market Size and Forecast, By Product Type
6.4.7.2. Market Size and Forecast, By Application
6.4.8. South Korea Bioresorbable Medical Material Market
6.4.8.1. Market Size and Forecast, By Product Type
6.4.8.2. Market Size and Forecast, By Application
6.4.9. Australia Bioresorbable Medical Material Market
6.4.9.1. Market Size and Forecast, By Product Type
6.4.9.2. Market Size and Forecast, By Application
6.4.10. Rest of Asia-Pacific Bioresorbable Medical Material Market
6.4.10.1. Market Size and Forecast, By Product Type
6.4.10.2. Market Size and Forecast, By Application
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product Type
6.5.3. Market Size and Forecast, By Application
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Bioresorbable Medical Material Market
6.5.5.1. Market Size and Forecast, By Product Type
6.5.5.2. Market Size and Forecast, By Application
6.5.6. South Africa Bioresorbable Medical Material Market
6.5.6.1. Market Size and Forecast, By Product Type
6.5.6.2. Market Size and Forecast, By Application
6.5.7. Saudi Arabia Bioresorbable Medical Material Market
6.5.7.1. Market Size and Forecast, By Product Type
6.5.7.2. Market Size and Forecast, By Application
6.5.8. Rest of LAMEA Bioresorbable Medical Material Market
6.5.8.1. Market Size and Forecast, By Product Type
6.5.8.2. Market Size and Forecast, By Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping Of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Medtronic
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Stryker Corporation.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Johnson And Johnson
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Boston Scientific Corporation
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Smith And Nephew Plc
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Zimmer Biomet Holdings, Inc.
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. B . Braun Melsungen AG
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. KLS Martin Group
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Dare Bioscience, Inc.
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Amedica Corporation
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 2. Bioresorbable Medical Material Market for Polylactide, by Region, 2024 - 2033 ($Billion)
Table 3. Bioresorbable Medical Material Market for Poly-L-Lactide, by Region, 2024 - 2033 ($Billion)
Table 4. Bioresorbable Medical Material Market for Poly-Dl-Lactide, by Region, 2024 - 2033 ($Billion)
Table 5. Bioresorbable Medical Material Market for Polyglycolide, by Region, 2024 - 2033 ($Billion)
Table 6. Bioresorbable Medical Material Market for Polycaprolactone, by Region, 2024 - 2033 ($Billion)
Table 7. Bioresorbable Medical Material Market for Others, by Region, 2024 - 2033 ($Billion)
Table 8. Global Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 9. Bioresorbable Medical Material Market for Drug Delivery, by Region, 2024 - 2033 ($Billion)
Table 10. Bioresorbable Medical Material Market for Medical Devices, by Region, 2024 - 2033 ($Billion)
Table 11. Bioresorbable Medical Material Market for Orthopedics, by Region, 2024 - 2033 ($Billion)
Table 12. Bioresorbable Medical Material Market for Others, by Region, 2024 - 2033 ($Billion)
Table 13. Bioresorbable Medical Material Market, by Region, 2024 - 2033 ($Billion)
Table 14. North America Bioresorbable Medical Material Market, by Country, 2024 - 2033 ($Billion)
Table 15. North America Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 16. North America Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 17. U.S. Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 18. U.S. Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 19. Canada Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 20. Canada Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 21. Mexico Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 22. Mexico Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 23. Europe Bioresorbable Medical Material Market, by Country, 2024 - 2033 ($Billion)
Table 24. Europe Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 25. Europe Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 26. France Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 27. France Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 28. Germany Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 29. Germany Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 30. Italy Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 31. Italy Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 32. Spain Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 33. Spain Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 34. UK Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 35. UK Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 36. Rest of Europe Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 37. Rest of Europe Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 38. Asia-Pacific Bioresorbable Medical Material Market, by Country, 2024 - 2033 ($Billion)
Table 39. Asia-Pacific Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 40. Asia-Pacific Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 41. China Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 42. China Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 43. Japan Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 44. Japan Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 45. India Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 46. India Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 47. South Korea Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 48. South Korea Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 49. Australia Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 50. Australia Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 51. Rest of Asia-Pacific Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 52. Rest of Asia-Pacific Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 53. LAMEA Bioresorbable Medical Material Market, by Country, 2024 - 2033 ($Billion)
Table 54. LAMEA Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 55. LAMEA Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 56. Brazil Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 57. Brazil Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 58. South Africa Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 59. South Africa Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 60. Saudi Arabia Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 61. Saudi Arabia Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 62. Rest of LAMEA Bioresorbable Medical Material Market, by Product Type, 2024 - 2033 ($Billion)
Table 63. Rest of LAMEA Bioresorbable Medical Material Market, by Application, 2024 - 2033 ($Billion)
Table 64. Medtronic: Key Executives
Table 65. Medtronic: Company Snapshot
Table 66. Medtronic: Operating Segments
Table 67. Medtronic: Product Portfolio
Table 68. Medtronic: Key Strategic Moves and Developments
Table 69. Stryker Corporation.: Key Executives
Table 70. Stryker Corporation.: Company Snapshot
Table 71. Stryker Corporation.: Operating Segments
Table 72. Stryker Corporation.: Product Portfolio
Table 73. Stryker Corporation.: Key Strategic Moves and Developments
Table 74. Johnson and Johnson: Key Executives
Table 75. Johnson and Johnson: Company Snapshot
Table 76. Johnson and Johnson: Operating Segments
Table 77. Johnson and Johnson: Product Portfolio
Table 78. Johnson and Johnson: Key Strategic Moves and Developments
Table 79. Boston Scientific Corporation: Key Executives
Table 80. Boston Scientific Corporation: Company Snapshot
Table 81. Boston Scientific Corporation: Operating Segments
Table 82. Boston Scientific Corporation: Product Portfolio
Table 83. Boston Scientific Corporation: Key Strategic Moves and Developments
Table 84. Smith and Nephew PLC: Key Executives
Table 85. Smith and Nephew PLC: Company Snapshot
Table 86. Smith and Nephew PLC: Operating Segments
Table 87. Smith and Nephew PLC: Product Portfolio
Table 88. Smith and Nephew PLC: Key Strategic Moves and Developments
Table 89. Zimmer Biomet Holdings, Inc.: Key Executives
Table 90. Zimmer Biomet Holdings, Inc.: Company Snapshot
Table 91. Zimmer Biomet Holdings, Inc.: Operating Segments
Table 92. Zimmer Biomet Holdings, Inc.: Product Portfolio
Table 93. Zimmer Biomet Holdings, Inc.: Key Strategic Moves and Developments
Table 94. B . Braun Melsungen AG: Key Executives
Table 95. B . Braun Melsungen AG: Company Snapshot
Table 96. B . Braun Melsungen AG: Operating Segments
Table 97. B . Braun Melsungen AG: Product Portfolio
Table 98. B . Braun Melsungen AG: Key Strategic Moves and Developments
Table 99. Kls Martin Group: Key Executives
Table 100. Kls Martin Group: Company Snapshot
Table 101. Kls Martin Group: Operating Segments
Table 102. Kls Martin Group: Product Portfolio
Table 103. Kls Martin Group: Key Strategic Moves and Developments
Table 104. Dare Bioscience, Inc.: Key Executives
Table 105. Dare Bioscience, Inc.: Company Snapshot
Table 106. Dare Bioscience, Inc.: Operating Segments
Table 107. Dare Bioscience, Inc.: Product Portfolio
Table 108. Dare Bioscience, Inc.: Key Strategic Moves and Developments
Table 109. Amedica Corporation: Key Executives
Table 110. Amedica Corporation: Company Snapshot
Table 111. Amedica Corporation: Operating Segments
Table 112. Amedica Corporation: Product Portfolio
Table 113. Amedica Corporation: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Bioresorbable Medical Material Market, 2024 - 2033
Figure 2. Segmentation of Bioresorbable Medical Material Market, 2024 - 2033
Figure 3. Top Investment Pocket in Bioresorbable Medical Material Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalbioresorbable Medical Material Market
Figure 10. Global Bioresorbable Medical Material Market Segmentation, by Product Type
Figure 11. Bioresorbable Medical Material Market for Polylactide, by Country, 2024 - 2033 ($Billion)
Figure 12. Bioresorbable Medical Material Market for Poly-L-Lactide, by Country, 2024 - 2033 ($Billion)
Figure 13. Bioresorbable Medical Material Market for Poly-Dl-Lactide, by Country, 2024 - 2033 ($Billion)
Figure 14. Bioresorbable Medical Material Market for Polyglycolide, by Country, 2024 - 2033 ($Billion)
Figure 15. Bioresorbable Medical Material Market for Polycaprolactone, by Country, 2024 - 2033 ($Billion)
Figure 16. Bioresorbable Medical Material Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 17. Global Bioresorbable Medical Material Market Segmentation, by Application
Figure 18. Bioresorbable Medical Material Market for Drug Delivery, by Country, 2024 - 2033 ($Billion)
Figure 19. Bioresorbable Medical Material Market for Medical Devices, by Country, 2024 - 2033 ($Billion)
Figure 20. Bioresorbable Medical Material Market for Orthopedics, by Country, 2024 - 2033 ($Billion)
Figure 21. Bioresorbable Medical Material Market for Others, by Country, 2024 - 2033 ($Billion)
Figure 22. Top Winning Strategies, by Year, 2021-2023*
Figure 23. Top Winning Strategies, by Development, 2021-2023*
Figure 24. Top Winning Strategies, by Company, 2021-2023*
Figure 25. Product Mapping of Top 10 Players
Figure 26. Competitive Dashboard
Figure 27. Competitive Heatmap: Bioresorbable Medical Material Market
Figure 28. Top Player Positioning, 2023
Figure 29. Medtronic: Net Sales, 2021-2023 ($Billion)
Figure 30. Medtronic: Revenue Share, by Segment, 2023 (%)
Figure 31. Medtronic: Revenue Share, by Region, 2023 (%)
Figure 32. Stryker Corporation.: Net Sales, 2021-2023 ($Billion)
Figure 33. Stryker Corporation.: Revenue Share, by Segment, 2023 (%)
Figure 34. Stryker Corporation.: Revenue Share, by Region, 2023 (%)
Figure 35. Johnson and Johnson: Net Sales, 2021-2023 ($Billion)
Figure 36. Johnson and Johnson: Revenue Share, by Segment, 2023 (%)
Figure 37. Johnson and Johnson: Revenue Share, by Region, 2023 (%)
Figure 38. Boston Scientific Corporation: Net Sales, 2021-2023 ($Billion)
Figure 39. Boston Scientific Corporation: Revenue Share, by Segment, 2023 (%)
Figure 40. Boston Scientific Corporation: Revenue Share, by Region, 2023 (%)
Figure 41. Smith and Nephew PLC: Net Sales, 2021-2023 ($Billion)
Figure 42. Smith and Nephew PLC: Revenue Share, by Segment, 2023 (%)
Figure 43. Smith and Nephew PLC: Revenue Share, by Region, 2023 (%)
Figure 44. Zimmer Biomet Holdings, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 45. Zimmer Biomet Holdings, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 46. Zimmer Biomet Holdings, Inc.: Revenue Share, by Region, 2023 (%)
Figure 47. B . Braun Melsungen AG: Net Sales, 2021-2023 ($Billion)
Figure 48. B . Braun Melsungen AG: Revenue Share, by Segment, 2023 (%)
Figure 49. B . Braun Melsungen AG: Revenue Share, by Region, 2023 (%)
Figure 50. Kls Martin Group: Net Sales, 2021-2023 ($Billion)
Figure 51. Kls Martin Group: Revenue Share, by Segment, 2023 (%)
Figure 52. Kls Martin Group: Revenue Share, by Region, 2023 (%)
Figure 53. Dare Bioscience, Inc.: Net Sales, 2021-2023 ($Billion)
Figure 54. Dare Bioscience, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 55. Dare Bioscience, Inc.: Revenue Share, by Region, 2023 (%)
Figure 56. Amedica Corporation: Net Sales, 2021-2023 ($Billion)
Figure 57. Amedica Corporation: Revenue Share, by Segment, 2023 (%)
Figure 58. Amedica Corporation: Revenue Share, by Region, 2023 (%)

Companies Mentioned

  • Medtronic
  • Stryker Corporation.
  • Johnson & Johnson
  • Boston Scientific Corporation
  • Smith & Nephew plc
  • Zimmer Biomet Holdings, Inc.
  • B . Braun Melsungen AG
  • KLS Martin Group
  • Dare Bioscience, Inc.
  • amedica corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages260
PublishedSeptember 2024
Forecast Period2023 - 2033
Estimated Market Value ( USD ) in 2023 $ 0.4 billion
Forecasted Market Value ( USD ) by 2033 $ 1.2 billion
Compound Annual Growth Rate10.6%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Bioresorbable Medical Material Market Report 2025 - Product Image

Bioresorbable Medical Material Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Bioresorbable Implants Market by Product Type, Material, Application, End User - Global Forecast 2025-2030 - Product Image

Bioresorbable Implants Market by Product Type, Material, Application, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Bioresorbable Polymers Market by Product (Fibers, Films, Micro-Particles), Form (Liquid, Powder, Solid), Manufacturing Process, Material Type, Application, End-User - Global Forecast 2025-2030 - Product Image

Bioresorbable Polymers Market by Product (Fibers, Films, Micro-Particles), Form (Liquid, Powder, Solid), Manufacturing Process, Material Type, Application, End-User - Global Forecast 2025-2030

  • Report
  • 181 Pages
  • Global
From
Bioresorbable Coronary Stents Market Size, Share & Trends Analysis Report By Material, By Drug, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Bioresorbable Coronary Stents Market Size, Share & Trends Analysis Report By Material, By Drug, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Coronary Bioresorbable Scaffolds Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Coronary Bioresorbable Scaffolds Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 92 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.